Relationship between high-sensitivity C-reactive protein and Clinical functional outcome after acute ischemic stroke in a Korean population

Cerebrovascular Diseases

Volumn 28, Issue 6, 2009, Pages 545-550

  Song, In Uk ^a   Kim, Joong Seok ^a   Kim, Yeong In ^a   Lee, Kwang Soo ^a   Jeong, Du Shin ^b   Chung, Sung Woo ^a,c  

^a The Catholic University of Korea   (South Korea)

^b Soonchunhyang University   (South Korea)

^c Bupyeong gu   (South Korea)

Author keywords

Functional disability; High sensitivity C reactive protein; Ischemic stroke

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; HIGH SENSITIVITY C REACTIVE PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PHYSICAL DISABILITY; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; SOUTH KOREA;

AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; DISABILITY EVALUATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE;

EID: 70350072258     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000247597     Document Type: Article

References (29)

1. Nakase T, Yamazaki T, Ogura N, Suzuki A, Nagata K: The impact of inflammation on the pathogenesis and prognosis of ischemic stroke. J Neurol Sci 2008; 271: 104-109.
2. Libby P: Inflammation in atherosclerosis. Nature 2002; 420: 868-874.
3. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith SC Jr, Taubert K, Tracy RP, Vinicor F; Centers for Disease Control and Prevention, American Heart Association: Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003; 107: 499-511.
4. Rothwell PM, Howard SC, Power DA, Gutnikov SA, Algra A, Van Gijn J, Clark TG, Murphy MF, Warlow CP: Fibrinogen concentration and risk of ischemic stroke and acute coronary events in 5,113 patients with transient ischemic attack and minor ischemic stroke. Stroke 2004; 35: 2300-2305.
5. Hoffann JA, Kafatos FC, Janeway CA, Ezekowitz RA: Phylogenetic perspective in innate immunity. Science 1999; 284: 1313-1318.
6. Tanne D, Benderly M, Goldbourt U, Hain M, Tenenbaum A, Fisman EZ, Matas Z, Adler Y, Zimmlichman R, Behar S: C-reactive protein as a predictor of incident ischemic stroke among patients with preexisting cardiovascular disease. Stroke 2006; 37: 1720-1724.
7. Winbeck K, Poppert H, Etgen T, Conrad B, Sander D: Prognostic relevance of early serial C-reactive protein measurements after first ischemic stroke. Stroke 2002; 33: 2459-2464.
8. Purroy F, Montaner J, Molina CA, Delgado P, Arenillas JF, Chacon P, Quintana M, Alvarez-Sabin J: C-reactive protein predicts further ischemic events in transient ischemic attack patients. Acta Neurol Scand 2007; 115: 60-66.
9. Haverkate F, Thompson SG, Pyke SD, Gallimore JR, Pepys MB: Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Lancet 1997; 349: 462-466.
10. Sakkinen P, Abbott RD, Curb JD, Rodriguez BL, Yano K, Tracy RP: C-reactive protein and myocardial infarction. J Clin Epidemiol 2002; 55: 445-451.
11. Tracy RP, Lemaitre RN, Psaty BM, Ives DG, Evans RW, Cushman M, Meilahn EN, Kuller LH: Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler Thromb Vasc Biol 1997; 17: 1121-1127.
12. Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH: Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 1998; 98: 731-733.
13. Di Napoli M, Papa F, Bocola V: C-reactive protein in ischemic stroke: an independent prognostic factor. Stroke 2001; 32: 917-924. (Pubitemid 32285161)
14. Zebrack JS, Anderson JL, Maycock CA, Horne BD, Bair TL, Muhlestein JB; Intermountain Heart Collaborative (IHC) Study Group: Usefulness of high-sensitivity C-reactive protein in predicting long-term risk of death or acute myocardial infarction in patients with unstable or stable angina pectoris or acute myocardial infarction. Am J Cardiol 2002; 89: 145-149.
15. Di Napoli M, Papa F, Bocola V: Prognostic influence of increased C-reactive protein and fibrinogen levels in ischemic stroke. Stroke 2001; 32: 133-138. (Pubitemid 32063837)
16. Masotti L, Ceccarelli E, Forconi S, Cappelli R: Prognostic role of C-reactive protein in very old patients with acute ischaemic stroke. J Intern Med 2005; 258: 145-152.
17. Wakugawa Y, Kiyohara Y, Tanizaki Y, Kubo M, Ninomiya T, Hata J, Doi Y, Okubo K, Oishi Y, Shikata K, Yonemoto K, Maebuchi D, Ibayashi S, Iida M: C-reactive protein and risk of first-ever ischemic and hemorrhagic stroke in a general Japanese population: the Hisayama Study. Stroke 2006; 37: 27-32.
18. Foulkes MA, Wolf PA, Price TR, Mohr JP, Hier DB: The Stroke Data Bank: design, methods, and baseline characteristics. Stroke 1988; 19: 547-554.
19. Muir KW, Weir CJ, Alwan W, Squire IB, Lees KR: C-reactive protein and outcome after ischemic stroke. Stroke 1999; 30: 981-985.
20. Youssef MY, Mojiminiyi OA, Abdella NA: Plasma concentrations of C-reactive protein and total homocysteine in relation to the severity and risk factors for cerebrovascular disease. Transl Res 2007; 150: 158-163.
21. Christensen H, Boysen G: C-reactive protein and white blood cell count increases in the first 24 h after acute stroke. Cerebrovasc Dis 2004; 18: 214-219.
22. Di Napoli M, Schwaninger M, Cappelli R, Ceccarelli E, Di Gianfilippo G, Donati C, Emsley HC, Forconi S, Hopkins SJ, Masotti L, et al: Evaluation of C-reactive protein measurement for assessing the risk and prognosis in ischemic stroke: a statement for health care professionals from the CRP Pooling Project members. Stroke 2005; 36: 1316-1329.
23. Eikelboom JW, Hankey GJ, Baker RI, Mc-Quillan A, Thom J, Staton J, Cole V, Yi Q: C-reactive protein in ischemic stroke and its etiologic subtypes. J Stroke Cerebrovasc Dis 2003; 12: 74-81. (Pubitemid 36506246)
24. Bos MJ, Schipper CM, Koudstaal PJ, Witteman JC, Hofman A, Breteler MM: High serum C-reactive protein level is not an independent predictor for stroke: the Rotterdam Study. Circulation 2006; 114: 1591-1598.
25. Arenillas JF, Alvarez-Sabín J, Molina CA, Chacón P, Montaner J, Rovira A, Ibarra B, Quintana M: C-reactive protein predicts further ischemic events in first-ever transient ischemic attack or stroke patients with intracranial large-artery occlusive disease. Stroke 2003; 34: 2463-2470.
26. Beamer NB, Coull BM, Clark WM, Hazel JS, Silberger JR: Interleukin-6 and interleukin-1 receptor antagonist in acute stroke. Ann Neurol 1995; 37: 800-805.
27. Van Dijk EJ, Prins ND, Vermeer SE, Vrooman HA, Hofman A, Koudstaal PJ, Breteler MM: C-reactive protein and cerebral small-vessel disease: the Rotterdam Scan Study. Circulation 2005; 112: 900-905.
28. Wada M, Nagasawa H, Kurita K, Koyama S, Arawaka S, Kawanami T, Tajima K, Daimon M, Kato T: Cerebral small vessel disease and C-reactive protein: results of a cross-sectional study in community-based Japanese elderly. J Neurol Sci 2008; 264: 43-49.
29. Schmidt R, Schmidt H, Pichler M, Enzinger C, Petrovic K, Niederkom K, Horner S, Ropele S, Watzinger N, Schumacher M, Berghold A, Kostner GM, Fazekas F: C-reactive protein, carotid atherosclerosis, and cerebral small-vessel disease: results of the Austrian Stroke Prevention Study. Stroke 2006; 37: 2910-2916.